日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mycobacterial acyl carrier protein suppresses TFEB activation and upregulates miR-155 to inhibit host defense

分枝杆菌酰基载体蛋白抑制 TFEB 活化并上调 miR-155 以抑制宿主防御

Seungwha Paik, Kyeong Tae Kim, In Soo Kim, Young Jae Kim, Hyeon Ji Kim, Seunga Choi, Hwa-Jung Kim, Eun-Kyeong Jo

A Dendritic Cell-Activating Rv1876 Protein Elicits Mycobacterium Bovis BCG-Prime Effect via Th1-Immune Response

树突状细胞激活 Rv1876 蛋白通过 Th1 免疫反应引发牛分枝杆菌 BCG 引发效应

Seunga Choi, Han-Gyu Choi, Yong Woo Back, Hye-Soo Park, Kang-In Lee, Sintayehu Kebede Gurmessa, Thuy An Pham, Hwa-Jung Kim

Mycobacterium tuberculosis RpfE-Induced Prostaglandin E2 in Dendritic Cells Induces Th1/Th17 Cell Differentiation

结核分枝杆菌 RpfE 诱导的树突状细胞前列腺素 E2 诱导 Th1/Th17 细胞分化

Hye-Soo Park, Seunga Choi, Yong-Woo Back, Kang-In Lee, Han-Gyu Choi, Hwa-Jung Kim

Recombinant Rv3261 protein of Mycobacterium tuberculosis induces apoptosis through a mitochondrion-dependent pathway in macrophages and inhibits intracellular bacterial growth

结核分枝杆菌重组Rv3261蛋白通过线粒体依赖性途径诱导巨噬细胞凋亡并抑制细胞内细菌生长

Kang-In Lee, Seunga Choi, Han-Gyu Choi, Sintayehu Gurmessa Kebede, Thi Binh Dang, Yong Woo Back, Hye-Soo Park, Hwa-Jung Kim

Mycobacterium tuberculosis Rv3463 induces mycobactericidal activity in macrophages by enhancing phagolysosomal fusion and exhibits therapeutic potential

结核分枝杆菌 Rv3463 通过增强吞噬溶酶体融合诱导巨噬细胞中的杀分枝杆菌活性并表现出治疗潜力

Hye-Soo Park, Yong Woo Back, Ki-Won Shin, Hyun Shik Bae, Kang-In Lee, Han-Gyu Choi, Seunga Choi, Hwang-Ho Lee, Chul Hee Choi, Jeong-Kyu Park, Hwa-Jung Kim

Mycobacterium tuberculosis Protein Rv3841 Activates Dendritic Cells and Contributes to a T Helper 1 Immune Response

结核分枝杆菌蛋白Rv3841激活树突状细胞并促进T辅助细胞1型免疫应答

Choi, Seunga; Choi, Han-Gyu; Shin, Ki-Won; Back, Yong Woo; Park, Hye-Soo; Lee, Jae Hwi; Kim, Hwa-Jung

Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice

Rv2299c 是一种新型结核分枝杆菌树突状细胞活化抗原,融合 ESAT-6 亚单位疫苗可为小鼠提供针对高毒力菌株 HN878 的增强和持久保护

Han-Gyu Choi, Seunga Choi, Yong Woo Back, Seungwha Paik, Hye-Soo Park, Woo Sik Kim, Hongmin Kim, Seung Bin Cha, Chul Hee Choi, Sung Jae Shin, Hwa-Jung Kim

Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis

核因子 κB 受体激活剂 (RANK) 信号复合物中的肿瘤坏死因子受体相关因子 6 (TRAF6) 与 Vav3 的相互作用增强破骨细胞生成

Jiyeon Yu, Hyeongseok Yun, Bongjin Shin, Yongjin Kim, Eui-Soon Park, Seunga Choi, Jungeun Yu, Dulshara Sachini Amarasekara, Sumi Kim, Jun-Ichiro Inoue, Matthew C Walsh, Yongwon Choi, Masamichi Takami, Jaerang Rho

Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential

结核分枝杆菌 Rv2882c 蛋白通过 TLR4 诱导巨噬细胞激活并表现出疫苗潜力

Han-Gyu Choi, Seunga Choi, Yong Woo Back, Hye-Soo Park, Hyun Shik Bae, Chul Hee Choi, Hwa-Jung Kim

Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction

肿瘤坏死因子 (TNF) 受体相关因子 (TRAF) 相互作用蛋白 (TRIP) 通过抑制 TRAF2-鞘氨醇 1-磷酸 (S1P) 相互作用,负向调节 TRAF2 泛素依赖性通路

Eui-Soon Park, Seunga Choi, Bongjin Shin, Jungeun Yu, Jiyeon Yu, Jung-Me Hwang, Hyeongseok Yun, Young-Ho Chung, Jong-Soon Choi, Yongwon Choi, Jaerang Rho